An worker inspects the Nicotiana benthamiana plants at Medicago greenhouse in Quebec City
They said the vaccine's overall efficacy rate against all variants of the coronavirus was 71%, except Omicron, which was not in circulation when the study was underway. Last week, infectious disease expert Anthony Fauci said though the focus is on Omicron, 99.9% cases in the United States were due to the Delta variant. "Delta continues to drive cases across the country, especially in those who are unvaccinated."
The Canadian health regulator in April accepted Medicago's application for a real-time review of the only home-grown COVID-19 vaccine to reach the most advanced level of trials.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Omicron v. delta: Battle of coronavirus mutants is criticalAs the omicron coronavirus variant spreads in southern Africa and pops up in countries all around the world, scientists are anxiously watching a battle play out that could determine the future of the pandemic. Can the latest competitor to the world-dominating delta overthrow it? “It’s still early days, but increasingly, data is starting to trickle in, suggesting that omicron is likely to outcompete delta in many, if not all, places,” said Dr. Jacob Lemieux, who monitors variants for a research collaboration led by Harvard Medical School.
Source: YahooSG - 🏆 3. / 71 Read more »
Medicago's plant-based vaccine trial shows 75.3% efficacy against Delta variantCanadian drug developer Medicago\u0027s plant-based COVID-19 vaccine candidate, enhanced by GlaxoSmithKline\u0027s booster, was 75.3 per cent effective against the Delta variant of the virus in a late stage study, the two companies said on Tuesday (Dec 7). They said the vaccine\u0027s overall efficacy rate against all va
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Medicago's plant-based vaccine trial shows 75.3per cent efficacy against Delta variantCanadian drug developer Medicago's plant-based COVID-19 vaccine candidate, enhanced by GlaxoSmithKline's booster, was 75.3per cent effective against the Delta variant of the virus in a late stage study, the two companies said on Tuesday.They said the vaccine's overall efficacy rate against all variants of
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Medicago's plant-based vaccine trial shows 75.3% efficacy against Delta variantCanadian drug developer Medicago\u0027s plant-based COVID-19 vaccine candidate, enhanced by GlaxoSmithKline\u0027s booster, was 75.3 per cent effective against the Delta variant of the virus in a late stage study, the two companies said on Tuesday (Dec 7). They said the vaccine\u0027s overall efficacy rate against all va
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Medicago's plant-based vaccine trial shows 75.3per cent efficacy against Delta variantCanadian drug developer Medicago's plant-based COVID-19 vaccine candidate, enhanced by GlaxoSmithKline's booster, was 75.3per cent effective against the Delta variant of the virus in a late stage study, the two companies said on Tuesday.They said the vaccine's overall efficacy rate against all variants of
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: BusinessTimes - 🏆 15. / 51 Read more »